About this trial
Using a four-week randomized, crossover study design, we will assess the impact of 2 weeks of a high bile acid-binding blenderized diet, compared to 2 weeks of a low bile acid-binding blenderized diet, on gastric and salivary bile acid concentrations within individual participants. Four weeks of an amino acid formula will be a comparator group.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
receive blenderized feeds or will start receiving blenderized feeds
have no known allergies to ingredients in blenderized feeds;
receive their bolus feeds within 30 minutes or less
can receive their feeds by syringe push
Disqualifiers
have undergone anti-reflux surgery
receive post-pyloric feeds
are allergic to any component of the administered diets
cannot receive their gastrostomy feeds over 30 minutes
Trial design
Crossover
Treatments tested in this trial
Low bile acid binding blenderized diet
DrugLow bile acid binding blenderized diet administered for 2 weeks
High bile acid binding blenderized diet
DrugHigh bile acid binding blenderized diet administered for 2 weeks
Treatment groups
Trial outcomes
Primary outcomes
Gastric bile acid concentration
differences in total gastric bile acid concentrations at the end of each diet period
Secondary outcomes
Gastric bile acid concentration
changes in gastric bile acid composition (e.g., change in the proportion of gastric conjugated:unconjugated bile acid) between diet periods
Symptom scores
changes in symptoms over the two weeks between diet periods
Salivary and stool bile acid concentrations
changes in the total salivary and stool BA concentrations between diet periods;
Serum complement 4 (C4)
changes in serum C4 between diet periods
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: